Victoria R van Trigt
Overview
Explore the profile of Victoria R van Trigt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
11
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Trigt V, Bakker L, Pelsma I, Zandbergen I, Jentus M, Kruit M, et al.
J Clin Endocrinol Metab
. 2024 Sep;
PMID: 39292628
Purpose: To evaluate patients with prolactinoma treated surgically in a time when elective prolactinoma surgery became routine in our center, using a comprehensive outcome set, focusing on preoperative assessments, surgical...
2.
van Trigt V, Bakker L, Lu H, Pelsma I, Verstegen M, van Furth W, et al.
Pituitary
. 2024 Jul;
27(5):614-624.
PMID: 39042164
Purpose: To assess the utility of [F]fluoroethyl-L-tyrosine PET co-registered with magnetic resonance imaging ([F]FET-PET/MRI) in patients with difficult-to-localize prolactinoma to inform clinical decision-making and (surgical) treatment planning. Methods: Retrospective cohort...
3.
van Trigt V, Zandbergen I, Pelsma I, Bakker L, Verstegen M, van Furth W, et al.
Pituitary
. 2023 Oct;
26(6):725-728.
PMID: 37897644
No abstract available.
4.
van Trigt V, Zandbergen I, Pelsma I, Bakker L, Verstegen M, van Furth W, et al.
Pituitary
. 2023 Sep;
26(5):611-621.
PMID: 37690076
Purpose: To describe care trajectories in patients with prolactinoma, aiming to clarify the rationale for surgery. Methods: Retrospective observational cohort study of consecutive patients with prolactinoma undergoing surgery from 2017...
5.
van Trigt V, Pelsma I, Biermasz N
Pituitary
. 2023 Apr;
26(3):307-317.
PMID: 37014498
Purpose: To describe quality and outcomes of patient-reported outcome (PRO) measures (PROMs) used in patients with refractory hormone-producing pituitary adenomas, and to provide an overview of PROs in these challenging...
6.
Pelsma I, Kroon H, van Trigt V, Pereira A, Kloppenburg M, Biermasz N, et al.
Pituitary
. 2022 Jun;
25(4):622-635.
PMID: 35726113
Purpose: Acromegalic arthropathy is a well-known phenomenon, occurring in most patients regardless of disease status. To date, solely hips, knees, hands, and spinal joints have been radiographically assessed. Therefore, this...
7.
van Trigt V, Pelsma I, Kroon H, Pereira A, van der Meulen C, Kloppenburg M, et al.
Pituitary
. 2021 Oct;
25(2):229-237.
PMID: 34687408
Purpose: Pain is a common symptom of acromegaly, impairing health-related quality of life (HR-QoL) significantly despite long-term disease remission. Neuropathic-like pain (NP-like) symptoms are invalidating, with great impact on HR-QoL....